NCT00685971 Cholecalciferol for Vitamin D in Adult Cystic Fibrosis (CF) Patients Status COMPLETED Phase NA
NCT00685035 Comparison of Airway Clearance Therapy in Cystic Fibrosis Using the Same VEST Therapy Device But With Different Settings Status COMPLETED Phase PHASE4
NCT00684346 18FDG-PET Imaging to Detect Changes in Airways Inflammation in Cystic Fibrosis Patients Status COMPLETED Phase PHASE3
NCT00680316 A Study of Pulmozyme® (Dornase Alpha) in 3- to 5-Year-Old Patients With Cystic Fibrosis Status TERMINATED Phase PHASE4
NCT00677560 The Natural History of Small Airways Physiology in Diseased and Healthy States Status COMPLETED Phase N/A
NCT00671736 Lancovutide (Moli1901) Inhalation Solution Study in Adolescents and Adults With Cystic Fibrosis Status COMPLETED Phase PHASE2
NCT00670579 Study About Complications of Totally Implanted Venous Access Devices (TIVADs) in People With Cystic Fibrosis (CF) Status COMPLETED Phase N/A
NCT00669760 Dissection of Staphylococcus Aureus Infection From Colonization in Cystic Fibrosis Patients Status COMPLETED Phase N/A
NCT00663975 Open Label Safety Study of DCI-1020 in Pediatric Cystic Fibrosis (CF) Patients Status WITHDRAWN Phase NA
NCT00662714 Early Diagnosis of Diabetes Mellitus in Patients With Cystic Fibrosis Status COMPLETED Phase PHASE3
NCT00662675 A Study of the Efficacy and Tolerability of Pancrelipase Microtablet (MT) Capsules for the Treatment of Cystic Fibrosis-dependent Exocrine Pancreatic Insufficiency Status COMPLETED Phase PHASE3
NCT00659529 Safety and Efficacy of Sildenafil in Cystic Fibrosis (CF) Lung Disease Status COMPLETED Phase PHASE1/PHASE2
NCT00645788 Study to Evaluate the Safety and Efficacy of Ciprofloxacin (Inhaled) in Patients With Cystic Fibrosis Status COMPLETED Phase PHASE2
NCT00638365 Dose Escalation Study of KB001 in Cystic Fibrosis Patients Infected With Pseudomonas Aeruginosa Status COMPLETED Phase PHASE1/PHASE2
NCT00635141 The Effect of Hypertonic Saline on the Lung Clearance Index in Patients With Cystic Fibrosis Status COMPLETED Phase PHASE3
NCT00633191 Anti-pseudomonas IgY to Prevent Infections in Cystic Fibrosis Status COMPLETED Phase PHASE1/PHASE2
NCT00630812 Long Term Administration of Inhaled Mannitol in Cystic Fibrosis Status COMPLETED Phase PHASE3